Frank H. Valone
2014
In 2014, Frank H. Valone earned a total compensation of $3.2M as Senior Fellow, Clinical Development formerly Chief Medical Officer at FibroGen, a 373% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $471,740 |
|---|---|
| Option Awards | $1,690,470 |
| Salary | $443,480 |
| Stock Awards | $540,000 |
| Other | $19,410 |
| Total | $3,165,100 |
Valone received $1.7M in option awards, accounting for 53% of the total pay in 2014.
Valone also received $471.7K in non-equity incentive plan, $443.5K in salary, $540K in stock awards and $19.4K in other compensation.
Rankings
In 2014, Frank H. Valone's compensation ranked 2,859th out of 13,032 executives tracked by ExecPay. In other words, Valone earned more than 78.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,859 out of 13,032 | 78th |
Division Manufacturing | 1,019 out of 4,966 | 80th |
Major group Chemicals And Allied Products | 328 out of 1,686 | 81st |
Industry group Drugs | 255 out of 1,365 | 81st |
Industry Pharmaceutical Preparations | 210 out of 1,043 | 80th |
Source: SEC filing on April 24, 2017.
Valone's colleagues
We found three more compensation records of executives who worked with Frank H. Valone at FibroGen in 2014.